HCW Biologics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, HCW Biologics Inc had 1.23M in cash and cash equivalents.

HCW Biologics Inc reported 21.76M in total liabilities as of the latest reported quarter, including 21.06M in current liabilities and 692.53K in non-current liabilities.

As of the latest reported quarter, HCW Biologics Inc's total assets were 24.52M, consisting of 2.28M in current assets and 22.24M in non-current assets.

HCW Biologics Inc reported 2.76M in total shareholders' equity as of the latest reported quarter.